Association of Lymphopenia with Short Term Outcomes of Sepsis Patients; a Brief Report
Archives of Academic Emergency Medicine,
Vol. 7 No. 1 (2019),
1 January 2019
,
Page e14
https://doi.org/10.22037/aaem.v7i1.117
Abstract
Introduction: Studies have claimed that low lymphocyte count is independently correlated with 28-day survival of sepsis patients. Therefore, this study aimed to evaluate the value of lymphopenia in predicting the short-term outcome of sepsis patients.
Methods: This cross-sectional study was performed on sepsis patients referred to the emergency department during an 8-month period and relationship of lymphopenia with 28-day mortality and probability of septic shock and readmission due to sepsis was assessed.
Results: 124 cases with the mean age of 66.12 ± 15.82 (21-90) years were studied (54.8% male). 81 (65.3%) cases had lymphopenia (59.3% male). Lymphopenic patients had a significantly higher mean age (p = 0.003), higher need for ICU admission (p < 0.001), higher prevalence of 28-day septic shock (p < 0.001), higher 28-day mortality (p < 0.001), higher probability of readmission due to sepsis (p = 0.048), and higher SOFA score (p < 0.001). During 28 days of follow up, 57 (46%) patients were expired. They had a higher prevalence of septic shock (p < 0.001) and higher SOFA score (p < 0.001). Multivariate analysis showed that septic shock (OR=364.6; 95% CI: 26.3 to 5051.7; p = 0.001) and lymphopenia (OR=19.2; 95% CI: 1.7 to 211.3; p = 0.016) were the independent predictors of 28-day mortality.
Conclusions: Based on the findings, lymphopenia was independently associated with higher 28-day mortality and lymphopenic patients were older than the control group and had a significantly higher need for ICU admission, higher probability of 28-day septic shock and readmission due to sepsis, and higher SOFA score.
- Lymphopenia
- sepsis
- prognosis
- emergency service
- hospital
How to Cite
References
Chung KP, Chang HT, Lo SC, Chang LY, Lin SY, Cheng A, et al. Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis. Shock (Augusta, Ga). 2015;43(6):569-75.
Macdonald SP, Williams JM, Shetty A, Bellomo R, Finfer S, Shapiro N, et al. Review article: Sepsis in the emergency department - Part 1: Definitions and outcomes. Emergency medicine Australasia : EMA. 2017;29(6):619-25.
Mirbaha S, Abushouk AI, Negida A, Rouhipour A, Baratloo A. The effect of fluid therapy on hemodynamic and venous blood gas parameters in patients with septic shock. Journal of Medical Physiology. 2016;1(2):55-9.
Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock (Augusta, Ga). 2014;42(5):383-91.
Bloos F. Clinical diagnosis of sepsis and the combined use of biomarkers and culture- and non-culture-based assays. Methods in molecular biology (Clifton, NJ). 2015;1237:247-60.
Baratloo A, Rahmati F, Rouhipour A, Motamedi M, Gheytanchi E, Amini F, et al. Correlation of Blood Gas Parameters with Central Venous Pressure in Patients with Septic Shock; a Pilot Study. Bulletin of emergency and trauma. 2014;2(2):77-81.
Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nature reviews Immunology. 2013;13(12):862-74.
Hattori Y, Hattori K, Suzuki T, Matsuda N. Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges. Pharmacology & therapeutics. 2017;177:56-66.
Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A. Leukocyte apoptosis and its significance in sepsis and shock. Journal of leukocyte biology. 2005;78(2):325-37.
Monserrat J, de Pablo R, Reyes E, Diaz D, Barcenilla H, Zapata MR, et al. Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients. Critical care (London, England). 2009;13(1):R26.
Felmet KA, Hall MW, Clark RS, Jaffe R, Carcillo JA. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. Journal of immunology (Baltimore, Md : 1950). 2005;174(6):3765-72.
Venet F, Davin F, Guignant C, Larue A, Cazalis MA, Darbon R, et al. Early assessment of leukocyte alterations at diagnosis of septic shock. Shock (Augusta, Ga). 2010;34(4):358-63.
Wyllie DH, Bowler ICJW, Peto TEA. Relation between lymphopenia and bacteraemia in UK adults with medical emergencies. Journal of clinical pathology. 2004;57(9):950-5.
Chien y-c, Chung k-p, Cheng j-s, Chang H-T, Yu c-j. Lymphopenia Is Associated With Worse Outcome In Patients With Severe Sepsis. D57 SEPSIS: OF MICE, METABOLOMICS, AND MAN: American Thoracic Society; 2012. p. A5992-A.
Markwart R, Condotta SA, Requardt RP, Borken F, Schubert K, Weigel C, et al. Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naïve T-cells but no enduring cell-autonomous defects in T-cell function. PloS one. 2014;9(12):e115094-e.
Li X, Xu Z, Pang X, Huang Y, Yang B, Yang Y, et al. Interleukin-10/lymphocyte ratio predicts mortality in severe septic patients. PLoS One. 2017;12(6):e0179050.
- Abstract Viewed: 444 times
- PDF Downloaded: 244 times
- HTML Downloaded: 66 times